DE69229436D1 - Verwendung von somatostatinanalogen zur behandlung von melanomen - Google Patents

Verwendung von somatostatinanalogen zur behandlung von melanomen

Info

Publication number
DE69229436D1
DE69229436D1 DE69229436T DE69229436T DE69229436D1 DE 69229436 D1 DE69229436 D1 DE 69229436D1 DE 69229436 T DE69229436 T DE 69229436T DE 69229436 T DE69229436 T DE 69229436T DE 69229436 D1 DE69229436 D1 DE 69229436D1
Authority
DE
Germany
Prior art keywords
somatostatin analogs
treating
melanoma
skin
treating melanomas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69229436T
Other languages
English (en)
Other versions
DE69229436T2 (de
Inventor
Arthur Bogden
Jacques-Pierre Moreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Bioscience Inc
Original Assignee
Ipsen Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Bioscience Inc filed Critical Ipsen Bioscience Inc
Publication of DE69229436D1 publication Critical patent/DE69229436D1/de
Application granted granted Critical
Publication of DE69229436T2 publication Critical patent/DE69229436T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69229436T 1991-02-08 1992-02-07 Verwendung von somatostatinanalogen zur behandlung von melanomen Expired - Fee Related DE69229436T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65286391A 1991-02-08 1991-02-08
PCT/US1992/001027 WO1992013554A1 (en) 1991-02-08 1992-02-07 Method of treating benign and malignant proliferative skin disease

Publications (2)

Publication Number Publication Date
DE69229436D1 true DE69229436D1 (de) 1999-07-22
DE69229436T2 DE69229436T2 (de) 1999-11-25

Family

ID=24618499

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229436T Expired - Fee Related DE69229436T2 (de) 1991-02-08 1992-02-07 Verwendung von somatostatinanalogen zur behandlung von melanomen

Country Status (12)

Country Link
US (1) US6087337A (de)
EP (1) EP0542934B1 (de)
JP (1) JPH05506254A (de)
AT (1) ATE181240T1 (de)
CA (1) CA2079896A1 (de)
DE (1) DE69229436T2 (de)
DK (1) DK0542934T3 (de)
ES (1) ES2134798T3 (de)
GR (1) GR3030856T3 (de)
IE (1) IE920416A1 (de)
PT (1) PT100111B (de)
WO (1) WO1992013554A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
AU2014280847B2 (en) * 2013-06-13 2019-07-04 Antisense Therapeutics Ltd Combination therapy

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
DK375789A (da) * 1988-08-18 1990-02-19 Syntex Inc Peptidderivater
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
ATE140237T1 (de) * 1989-12-08 1996-07-15 Univ Tulane Oktapeptidanaloge von somatostatin mit threonin in position 6
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
GR3030856T3 (en) 1999-11-30
DE69229436T2 (de) 1999-11-25
EP0542934A4 (en) 1993-07-07
WO1992013554A1 (en) 1992-08-20
EP0542934B1 (de) 1999-06-16
PT100111A (pt) 1993-06-30
PT100111B (pt) 1999-06-30
IE920416A1 (en) 1992-08-12
EP0542934A1 (de) 1993-05-26
CA2079896A1 (en) 1992-08-09
ATE181240T1 (de) 1999-07-15
JPH05506254A (ja) 1993-09-16
ES2134798T3 (es) 1999-10-16
DK0542934T3 (da) 1999-11-22
US6087337A (en) 2000-07-11

Similar Documents

Publication Publication Date Title
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE3689363D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK130387A (da) Transglutaminase inhibitorer
DE69815527D1 (de) Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
ES502656A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
DE68907423D1 (de) Behandlung der akne.
DK57882A (da) Fremgangsmaade til fremstilling af tetrahydronaphthalen-og indanderivater
DE69229436D1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ES502654A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
CY1106300T1 (el) ΧΡΗΣΗ ΑΡΩΜΑΤΙΚΩΝ ΠΟΛΥΚΥΚΛΙΚΩΝ ΕΝΩΣΕΩΝ ΣΑΝ ΕΝEPΓΟΠΟΙΗΤΩΝ ΤΩΝ ΥΠΟΔΟΧΕΩΝ ΤΟΥ ΤΥΠΟΥ PPARs ΣΕ ΜΙΑ ΚΑΛΛΥΝΤΙΚΗ Ή ΦΑΡΜΑΚΕΥΤΙΚΗ ΣΥΝΘΕΣΗ
ATE419346T1 (de) Hemmung der bildung von atherosklerotischen wunden mittels afabp antisens nukleinsäuren
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE149840T1 (de) Behandlung von leberkrebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee